Table 1 Laboratory research indicators of the patient
From: Neuromyelitis Optica spectrum disorder complicated with pure red cell aplasia: a case report
Indicator | Reference | Value |
|---|---|---|
Cerebrospinal fluid | Â | Â |
Proteins | 0.15–0.45 g/L | 0.77 g/L |
Red cells | ≤0 | 10 × 106/L |
White blood cells | 0–15 × 106/L | 400 × 106/L |
CSF-IgA | 0–5 mg/L | 12.1 mg/L |
CSF-IgG | 0–34 mg/L | 114 mg/L |
CSF-IgM | 0-1.3Â mg/L | 4.39Â mg/L |
Plasma | Â | Â |
LDH | 0–30 IU/L | 35 IU/L |
AQP-4-IgG | Â | Positive 1:320 |
Serum immunological examination | Â | Â |
Antithyroglobulin antibody | 0–16 AU/ml | 75.5 AU/ml |
Thyroperoxidase antibody | 0–60 IU/ml | 67.2 IU/ml |
Anti-SSA-52 | 0–25 AU/ml | 51.71 AU/ml |
Anti-mitochondrial antibody-M | 0–16 AU/ml | 75.5 AU/ml () |
Antinuclear antibody | Â | Positive, 1/1280 cytoplasmic, 1/640 granular. |
Blood cells at 4 months after diagnosis of NOMSD | Â | Â |
Hemoglobin | 110–150 g/L | 65 g/L |
Platelets | 100–300 × 109/L | 209 × 109/L |
White blood cells | 4–10 × 109/L | 9.02 × 109/L |
Mean corpuscular volume | 80–100 fl. | 92.1 fl. |
Mean corpuscular hemoglobin concentration | 320–360 g/L | 333 g/L |
Reticulocyte | 22–84 × 109/L | 0.11% |